Wednesday, June 10, 2026

pharma Β· Inflammatory Bowel Disease (IBD) Β· Melanoma Β· IRON

Disc Medicine

Disc Medicine clinical programs β€” 59 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US HQ
165 Employees
Public company Type
IRON Β· NYSE Ticker
Company details
Status
Public
HQ
321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US
Employees
165
Programs
308
Drugs
442
Patents
706
Intelligence Β· Clinical Programs

Disc Medicine projects

59 ClinicalTrials.gov programs sponsored by Disc Medicine.

Disc Medicine has 59 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

Page 1 of 2
  1. -

    Disc Medicine

    Resectable colorectal rectal metastases without extrahepatic disease

    phase 3 small molecule active

    1 trial
  2. 115747

    Disc Medicine

    Metastatic renal cell carcinoma

    phase 3 small molecule active

    1 trial
  3. 116130

    Disc Medicine

    Parkinson's disease

    phase 3 small molecule active

    1 trial
  4. 14395

    Disc Medicine

    ABC borderline resectable pancreatic cancer

    phase 3 other active

    1 trial
  5. 18-791

    Disc Medicine

    Brain injury in neonates with critical congenital heart disease requiring cardiac surgery with cardiopulmonary bypass.

    phase 3 small molecule active

    1 trial
  6. 202100617

    Disc Medicine

    Combined endpoint of all-cause mortality, kidney failure, and hospitalization for heart failure in the overall study population

    phase 3 small molecule active

    1 trial
  7. 22817

    Disc Medicine

    chronic kidney disease

    phase 3 small molecule active

    1 trial
  8. 89Zr-CED88004S

    Disc Medicine

    Large B-cell lymphoma

    phase 3 small molecule active

    1 trial
  9. AchilleS tendinoPathy treated with cortIcosteRoid injEctions.

    Disc Medicine

    Achilles tendinopathy

    phase 3 other active

    1 trial
  10. Bitopertin

    Disc Medicine

    X-Linked Protoporphyria (XLP), Erythropoietic Protoporphyria (EPP)

    phase 3 small molecule active

    1 trial
  11. Bitopertin, Matching Placebo

    Disc Medicine

    X-Linked Protoporphyria (XLP), Erythropoietic Protoporphyria (EPP)

    phase 3 small molecule active

    1 trial
  12. CAPECITABINE

    Disc Medicine

    Salivary Duct Carcinoma

    phase 3 small molecule active

    1 trial
  13. CETUXIMAB

    Disc Medicine

    oral squamous cell carcinoma

    phase 3 small molecule active

    1 trial
  14. Concurrent chemotherapy

    Disc Medicine

    Uterine Cervical Neoplasms

    phase 3 small molecule active

    1 trial
  15. DAPAGLIFLOZIN, PLACEBO

    Disc Medicine

    Hypomagnesemia due to HNF1beta mutation

    phase 3 small molecule active

    1 trial
  16. DIDaC/ NVALT35

    Disc Medicine

    Patients with advanced, metastatic NSCLC that have not progressed on a standard of care immunotherapy regimen 6 months after initiation of first line treatment.

    phase 3 small molecule active

    1 trial
  17. DISC-1459

    Disc Medicine

    Erythropoietic Protoporphyria

    phase 3 small molecule active

    2 trials
  18. ETIDRONATE DISODIUM ORAL CAPSULES 400 MG

    Disc Medicine

    Pseudoxanthoma Elasticum

    phase 3 small molecule active

    1 trial
  19. FET

    Disc Medicine

    ACTH-dependent hypercortisolism

    phase 3 small molecule active

    1 trial
  20. FLUOROURACIL for Rectal cancer

    Disc Medicine

    Rectal cancer

    phase 3 small molecule active

    1 trial
  21. GALLIUM (68GA) CHLORIDE, TILMANOCEPT

    Disc Medicine

    Carcinoma of the parotid gland

    phase 3 small molecule active

    1 trial
  22. GALLIUM (68GA) CHLORIDE, TILMANOCEPT

    Disc Medicine

    Endometrial cancer, uterine cancer

    phase 3 small molecule active

    1 trial
  23. Glucose 5% 50 ml

    Disc Medicine

    Apnea of prematurity

    phase 3 small molecule active

    1 trial
  24. HEPARIN , NADROPARIN

    Disc Medicine

    All patients who receive ECMO treatment during the study period in one the participating centers from which (deferred) informed consent is obtained. Patients in whom the ECMO is only used to bridge a procedure like a high risk percutaneous coronary intervention or during surgery are excluded.

    phase 3 small molecule active

    1 trial
  25. INTENSIFY BD

    Disc Medicine

    Bipolar depression

    phase 3 small molecule active

    1 trial
  26. INTENSIFY MDD

    Disc Medicine

    Major depressive disorder

    phase 3 small molecule active

    1 trial
  27. Instant MSC Product accompanying Autologous Chondron Transplantation (IMPACT)

    Disc Medicine

    Symptomatic articular cartilage lesion of the knee (femoral condyles or trochlea)

    phase 3 small molecule active

    1 trial
  28. Insulatard 100 international units/ml suspens... for Delirium

    Disc Medicine

    Delirium

    phase 3 small molecule active

    1 trial
  29. Irinotecan HCl-trihydraat Accord /ml concentr...

    Disc Medicine

    Non-metastatic resectable pancreatic cancer

    phase 3 small molecule active

    1 trial
  30. Irinotecan HCl-trihydraat Fresenius Kabi /ml

    Disc Medicine

    non-metastatic (borderline) resectable pancreatic cancer

    phase 3 small molecule active

    1 trial
  31. KEYTRUDA 25 mg/mL concentrate for solution for infusion

    Disc Medicine

    Advanced NSCLC

    phase 3 small molecule active

    1 trial
  32. Ketanest-S 25 Multi-dose for Non-psychotic therapy resistant…

    Disc Medicine

    Non-psychotic therapy resistant unipolar depression

    phase 3 small molecule active

    1 trial
  33. Kyprolis powder for relapsed/refractory multiple my…

    Disc Medicine

    relapsed/refractory multiple myeloma

    phase 3 small molecule active

    1 trial
  34. LEUPRORELIN

    Disc Medicine

    polycystic liver disease

    phase 3 small molecule active

    1 trial
  35. LIOTHYRONINE for Hypothyroidism Triiodothyronine…

    Disc Medicine

    Hypothyroidism Triiodothyronine Quality of Life Persistant complaints

    phase 3 small molecule active

    1 trial
  36. Lactose monohydrate for Chronic low back pain

    Disc Medicine

    Chronic low back pain

    phase 3 small molecule active

    1 trial
  37. Leflunomide Mylan for polymyalgia rheumatica

    Disc Medicine

    polymyalgia rheumatica

    phase 3 small molecule active

    1 trial
  38. METFORMIN for PASC: post-acute sequelae of SARS-CoV-2 infection

    Disc Medicine

    PASC: post-acute sequelae of SARS-CoV-2 infection

    phase 3 small molecule active

    1 trial
  39. METFORMIN, COLCHICINE

    Disc Medicine

    PASC: post-acute sequelae of SARS-CoV-2 infection

    phase 3 small molecule active

    1 trial
  40. Modiodal 100 mg tabletten, PLACEBO

    Disc Medicine

    Inflammatory bowel disease, Fatigue

    phase 3 small molecule active

    1 trial
  41. NCT02735707

    Disc Medicine

    Respiratory tract infection

    phase 3 small molecule active

    1 trial
  42. NL79088.041.21

    Disc Medicine

    Primary antibody deficiency: - Unclassified antibody deficiency (unPAD) - IgA deficiency - Specific polysaccharide antibody deficiency (SPAD) - IgG subclass deficiency (IgSD) - Common variable immunodeficiency (CVID) - Agammaglobulinemia (X-linked or otherwise)

    phase 3 small molecule active

    1 trial
  43. NL79665.058.22

    Disc Medicine

    Cluster headache

    phase 3 small molecule active

    1 trial
  44. OPDIVO 10 mg/mL concentrate for solution for infusion.

    Disc Medicine

    oesophageal cancer

    phase 3 small molecule active

    1 trial
  45. PLASMA for Coagulation in pediatric cardia…

    Disc Medicine

    Coagulation in pediatric cardiac surgery

    phase 3 small molecule active

    1 trial
  46. PROGRAF for lung transplantation

    Disc Medicine

    lung transplantation

    phase 3 small molecule active

    1 trial
  47. Placebo

    Disc Medicine

    Erythropoietic Protoporphyria (EPP)

    phase 3 small molecule active

    1 trial
  48. Placebo Colchicine tablets for Aortic Valve Calcification, Inf…

    Disc Medicine

    Aortic Valve Calcification, Inflammation, Calcification, Aortic Valve Disease, Cardiovascular Diseases, Aortic Valve Stenosis

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Disc Medicine have?

59 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.